[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361756-105":59,"doc-detail-361756-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","revolutionizing-lung-cancer-treatment-harnessing-exosomes-as-early-diagnostic-biomarkers-therapeutics-and-nano-delivery-platforms","Revolutionizing lung cancer treatment - harnessing exosomes as early diagnostic biomarkers, therapeutics and nano-delivery platforms","","Lung cancer remains a major global health challenge with high morbidity and mortality, and conventional treatments like chemotherapy and surgery often show limited effectiveness due to costs, side effects, and poor prognosis. This review highlights exosomes as multifunctional nanovesicles that participate in lung cancer development, diagnosis, treatment, and prognosis. Owing to natural intercellular communication, biocompatibility, low toxicity, prolonged circulation, and biodegradability, exosomes are discussed as drug-delivery platforms and as diagnostic and prognostic biomarkers, aiming to enable more personalized therapies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/revolutionizing-lung-cancer-treatment-harnessing-exosomes-as-early-diagnostic-biomarkers-therapeutics-and-nano-delivery-platforms/361756/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/revolutionizing-lung-cancer-treatment-harnessing-exosomes-as-early-diagnostic-biomarkers-therapeutics-and-nano-delivery-platforms/361756.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does the review emphasize new approaches for lung cancer treatment?","Question",{"text":112,"@type":113},"The review notes that current options such as chemotherapy and surgery are constrained by high costs, significant side effects, and often poor prognosis, leading to poor survival outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What key properties make exosomes promising for lung cancer applications?",{"text":117,"@type":113},"Exosomes are presented as effective due to natural intercellular communication, excellent biocompatibility, minimal toxicity, prolonged blood circulation, and biodegradability, supporting both diagnostics and therapy.",{"name":119,"@type":110,"acceptedAnswer":120},"How are exosomes used for early diagnostic biomarker discovery?",{"text":121,"@type":113},"The review explains that exosomal components such as proteins and miRNA have demonstrated significant potential as biomarkers for early lung cancer diagnosis, including evidence from exosome-based liquid biopsy approaches.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361756,1790216541,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Xiao et al. Journal of Nanobiotechnology (2025) 23:232  \n[https://doi.org/10.1186/s12951-025-03306-0](https://doi.org/10.1186/s12951-025-03306-0)  \nJournal of Nanobiotechnology  \n REVIEW Open Access  \nRevolutionizing lung cancer treatment:   harnessing exosomes as early diagnostic biomarkers, therapeutics and nano-delivery platforms  \nQiyao Xiao1, Minhong Tan1, Ge Yan1 and Lihua Peng1,2*  \nAbstract  \nLung cancer, known for its high morbidity and mortality rates, remains one of the most critical health challenges globally. Conventional treatment options, such as chemotherapy and surgery, are often limited by high costs, significant side effects, and often yield a poor prognosis. Notably, recent research has shed light on the potential therapeutic roles of exosomes, which essentially influence lung cancer’s development, diagnosis, treatment, and prognosis. Exosomes have been revealed for their exceptional properties, including natural intercellular communication, excellent biocompatibility, minimal toxicity, prolonged blood circulation ability, and biodegradability. These unique characteristics position exosomes as highly effective drug delivery systems, nanotherapeutics, and potential diagnostic and prognostic biomarkers in lung cancer. This review provides a comprehensive review of the physiological and pathological roles of exosomes in lung cancer, emphasizing their potential as innovative diagnostic biomarkers, therapeutics, and delivery platforms. By harnessing their unique properties, exosomes are poised to revolutionize the diagnosis and treatment of lung cancer, offering a promising avenue for more personalized and effective therapies.  \nKeywords Exosomes, Lung cancer, Diagonosis, Nanotherapeutics, Drug delivery  \n*Correspondence: Lihua Peng [lhpeng@zju.edu.cn](lhpeng@zju.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nXiao et al. Journal of Nanobiotechnology (2025) 23:232 Page 2 of 19  \nGraphical abstract  \nIntroduction  \nLung cancer, arising from the bronchial glands or mucosa, remains the leading cause of cancer-related mortality worldwide, with 2.48 million new cases reported in 2022, accounting for 12.4% of all cancer diagnoses globally [1, 2]. Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are two primary pathological subtypes of lung cancer, with NSCLC constituting 80–85% of cases [3]. Despite advancements in treatments such as surgery, chemotherapy, radiotherapy, immunotherapy, and targeted therapies, these approaches are often hindered by  \ndrug resistance, recurrence, and metastasis, resulting in poor survival rates. It is urgently needed to develop individualized strategies for the treatment of lung cancer.  \nExosomes are nanovesicles composed of lipid bilayer membranes, which have emerged as key mediators in intercellula","cbCaik4BPWZG3GPx","https://ap.wps.com/l/cbCaik4BPWZG3GPx","pdf",5016450,"English","# Introduction\n## Exosomes in lung cancer: roles and therapeutic relevance\n## Exosome diagnostics and biomarker potential\n# Exosome biogenesis and its role in lung cancer pathology\n## The biogenesis of the exosomes","[{\"question\":\"Why does the review emphasize new approaches for lung cancer treatment?\",\"answer\":\"The review notes that current options such as chemotherapy and surgery are constrained by high costs, significant side effects, and often poor prognosis, leading to poor survival outcomes.\"},{\"question\":\"What key properties make exosomes promising for lung cancer applications?\",\"answer\":\"Exosomes are presented as effective due to natural intercellular communication, excellent biocompatibility, minimal toxicity, prolonged blood circulation, and biodegradability, supporting both diagnostics and therapy.\"},{\"question\":\"How are exosomes used for early diagnostic biomarker discovery?\",\"answer\":\"The review explains that exosomal components such as proteins and miRNA have demonstrated significant potential as biomarkers for early lung cancer diagnosis, including evidence from exosome-based liquid biopsy approaches.\"}]","Revolutionizing lung cancer treatment - harnessing exosomes as early diagnostic biomarkers, therapeutics and nano-delivery platforms | PDF",1790145512,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48e54910d6955e2ef724c49b514939e4.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7271041a8220635d9aa4082ecdee9556.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4462ee24611e7b58f1ee78cd5176bc95.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ec97bec7e1c993b01f0a000ee07ba74.webp",980,1301]